Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study

MLA

Karin Palmblad, et al. “Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study.” Arthritis & Rheumatology (Hoboken, N.J.), vol. 73, no. 2, Dec. 2020, pp. 336–46. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bf0f52432191e269455a0e50dc693962&authtype=sso&custid=ns315887.

APA

Karin Palmblad, Gerd Horneff, Ken Abrams, X Wei, Rayfel Schneider, Vyacheslav Chasnyk, Alberto Martini, Jordi Anton, Katherine Marzan, Carine Wouters, Tamás Constantin, Ekaterina Alexeeva, Hermine I. Brunner, Pierre Quartier, Nicolino Ruperto, Alan Slade, & Nico M Wulffraat. (2020). Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study. Arthritis & Rheumatology (Hoboken, N.J.), 73(2), 336–346.

Chicago

Karin Palmblad, Gerd Horneff, Ken Abrams, X Wei, Rayfel Schneider, Vyacheslav Chasnyk, Alberto Martini, et al. 2020. “Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study.” Arthritis & Rheumatology (Hoboken, N.J.) 73 (2): 336–46. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bf0f52432191e269455a0e50dc693962&authtype=sso&custid=ns315887.